tiprankstipranks
Trending News
More News >
Healthequity (HQY)
NASDAQ:HQY
US Market

Healthequity (HQY) Stock Forecast & Price Target

Compare
819 Followers
See the Price Targets and Ratings of:

HQY Analyst Ratings

Strong Buy
13Ratings
Strong Buy
12 Buy
1 Hold
0 Sell
Based on 13 analysts giving stock ratings to
Healthequity
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

HQY Stock 12 Month Forecast

Average Price Target

$119.08
▲(5.32%Upside)
Based on 13 Wall Street analysts offering 12 month price targets for Healthequity in the last 3 months. The average price target is $119.08 with a high forecast of $130.00 and a low forecast of $104.00. The average price target represents a 5.32% change from the last price of $113.06.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"76":"$76","131":"$131","89.75":"$89.8","103.5":"$103.5","117.25":"$117.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":130,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$130.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":119.08,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$119.08</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":104,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$104.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[76,89.75,103.5,117.25,131],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2024","6":"Dec<br/>2024","9":"Mar<br/>2025","12":"Jun<br/>2025","25":"Jun<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,102.81,104.90153846153846,106.99307692307693,109.08461538461539,111.17615384615385,113.26769230769231,115.35923076923078,117.45076923076923,119.5423076923077,121.63384615384615,123.72538461538463,125.81692307692308,127.90846153846154,{"y":130,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,102.81,104.06153846153846,105.31307692307692,106.56461538461538,107.81615384615385,109.06769230769231,110.31923076923077,111.57076923076923,112.82230769230769,114.07384615384615,115.32538461538462,116.57692307692308,117.82846153846154,{"y":119.08,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,102.81,102.90153846153846,102.99307692307693,103.08461538461539,103.17615384615385,103.26769230769231,103.35923076923078,103.45076923076923,103.54230769230769,103.63384615384615,103.72538461538461,103.81692307692308,103.90846153846154,{"y":104,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":81.68,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":86.62,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":77.87,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":79.56,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":80.27,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":86.33,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":101.66,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":95.95,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":110.42,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":109.76,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":87.05,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":87.95,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":102.81,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$130.00Average Price Target$119.08Lowest Price Target$104.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on HQY
TipRanks AITipRanks
Not Ranked
TipRanks
$126
Buy
11.45%
Upside
Reiterated
06/05/25
Healthequity's strong financial performance and positive earnings call insights are the most significant strengths, showcasing robust growth and strategic initiatives. However, technical indicators suggest caution due to potential overbought conditions, and the high P/E ratio indicates valuation concerns.
Deutsche Bank  Analyst forecast on HQY
George HillDeutsche Bank
Deutsche Bank
$98$115
Buy
1.72%
Upside
Reiterated
06/05/25
HealthEquity price target raised to $115 from $98 at Deutsche BankHealthEquity price target raised to $115 from $98 at Deutsche Bank
Bank of America Securities Analyst forecast on HQY
Allen LutzBank of America Securities
Bank of America Securities
$110$125
Buy
10.56%
Upside
Reiterated
06/04/25
Healthequity's Strong Financial Performance and Strategic Positioning Earns Buy Rating from Analyst
KeyBanc
$100$125
Buy
10.56%
Upside
Reiterated
06/04/25
Healthequity (HQY) Receives a Buy from KeyBanc
Wells Fargo Analyst forecast on HQY
Stan BerenshteynWells Fargo
Wells Fargo
$125
Buy
10.56%
Upside
Reiterated
06/04/25
Strong Financial Performance and Strategic Growth Opportunities Drive Buy Rating for Healthequity
Citizens JMP
$110$117
Buy
3.48%
Upside
Reiterated
06/04/25
HealthEquity price target raised to $117 from $110 at Citizens JMPHealthEquity price target raised to $117 from $110 at Citizens JMP
BTIG
$130
Buy
14.98%
Upside
Reiterated
06/04/25
Healthequity's Strong Financial Performance and Strategic Initiatives Drive Buy Rating
Goldman Sachs Analyst forecast on HQY
David RomanGoldman Sachs
Goldman Sachs
$94$104
Hold
-8.01%
Downside
Reiterated
06/03/25
Healthequity (HQY) Receives a Hold from Goldman Sachs
RBC Capital Analyst forecast on HQY
Daniel PerlinRBC Capital
RBC Capital
$112$117
Buy
3.48%
Upside
Reiterated
06/03/25
RBC Capital Remains a Buy on Healthequity (HQY)
J.P. Morgan Analyst forecast on HQY
Anne SamuelJ.P. Morgan
J.P. Morgan
Buy
Reiterated
05/13/25
Analysts Are Bullish on These Healthcare Stocks: Sanofi (SNYNF), Healthequity (HQY)
Barrington Analyst forecast on HQY
Alexander ParisBarrington
Barrington
$112
Buy
-0.94%
Downside
Reiterated
04/11/25
Analysts' Top Healthcare Picks: Healthequity (HQY), Cingulate Inc (CING)
Raymond James Analyst forecast on HQY
Gregory PetersRaymond James
Raymond James
$120$115
Buy
1.72%
Upside
Upgraded
03/25/25
Healthequity (HQY) was upgraded to a Buy Rating at Raymond James
Mizuho Securities Analyst forecast on HQY
Steven ValiquetteMizuho Securities
Mizuho Securities
$126
Buy
11.45%
Upside
Reiterated
03/19/25
Buy Rating Affirmed for Healthequity Amid Strong Revenue Outlook and Growth Potential
Jefferies
$118
Buy
4.37%
Upside
Reiterated
03/18/25
Healthequity's Strong Performance and Growth Potential Justifies Buy Rating Despite Cyber Cost Challenges
Barclays
$104
Buy
-8.01%
Downside
Assigned
11/13/24
Healthequity (HQY) Receives a Buy from Barclays
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on HQY
TipRanks AITipRanks
Not Ranked
TipRanks
$126
Buy
11.45%
Upside
Reiterated
06/05/25
Healthequity's strong financial performance and positive earnings call insights are the most significant strengths, showcasing robust growth and strategic initiatives. However, technical indicators suggest caution due to potential overbought conditions, and the high P/E ratio indicates valuation concerns.
Deutsche Bank  Analyst forecast on HQY
George HillDeutsche Bank
Deutsche Bank
$98$115
Buy
1.72%
Upside
Reiterated
06/05/25
HealthEquity price target raised to $115 from $98 at Deutsche BankHealthEquity price target raised to $115 from $98 at Deutsche Bank
Bank of America Securities Analyst forecast on HQY
Allen LutzBank of America Securities
Bank of America Securities
$110$125
Buy
10.56%
Upside
Reiterated
06/04/25
Healthequity's Strong Financial Performance and Strategic Positioning Earns Buy Rating from Analyst
KeyBanc
$100$125
Buy
10.56%
Upside
Reiterated
06/04/25
Healthequity (HQY) Receives a Buy from KeyBanc
Wells Fargo Analyst forecast on HQY
Stan BerenshteynWells Fargo
Wells Fargo
$125
Buy
10.56%
Upside
Reiterated
06/04/25
Strong Financial Performance and Strategic Growth Opportunities Drive Buy Rating for Healthequity
Citizens JMP
$110$117
Buy
3.48%
Upside
Reiterated
06/04/25
HealthEquity price target raised to $117 from $110 at Citizens JMPHealthEquity price target raised to $117 from $110 at Citizens JMP
BTIG
$130
Buy
14.98%
Upside
Reiterated
06/04/25
Healthequity's Strong Financial Performance and Strategic Initiatives Drive Buy Rating
Goldman Sachs Analyst forecast on HQY
David RomanGoldman Sachs
Goldman Sachs
$94$104
Hold
-8.01%
Downside
Reiterated
06/03/25
Healthequity (HQY) Receives a Hold from Goldman Sachs
RBC Capital Analyst forecast on HQY
Daniel PerlinRBC Capital
RBC Capital
$112$117
Buy
3.48%
Upside
Reiterated
06/03/25
RBC Capital Remains a Buy on Healthequity (HQY)
J.P. Morgan Analyst forecast on HQY
Anne SamuelJ.P. Morgan
J.P. Morgan
Buy
Reiterated
05/13/25
Analysts Are Bullish on These Healthcare Stocks: Sanofi (SNYNF), Healthequity (HQY)
Barrington Analyst forecast on HQY
Alexander ParisBarrington
Barrington
$112
Buy
-0.94%
Downside
Reiterated
04/11/25
Analysts' Top Healthcare Picks: Healthequity (HQY), Cingulate Inc (CING)
Raymond James Analyst forecast on HQY
Gregory PetersRaymond James
Raymond James
$120$115
Buy
1.72%
Upside
Upgraded
03/25/25
Healthequity (HQY) was upgraded to a Buy Rating at Raymond James
Mizuho Securities Analyst forecast on HQY
Steven ValiquetteMizuho Securities
Mizuho Securities
$126
Buy
11.45%
Upside
Reiterated
03/19/25
Buy Rating Affirmed for Healthequity Amid Strong Revenue Outlook and Growth Potential
Jefferies
$118
Buy
4.37%
Upside
Reiterated
03/18/25
Healthequity's Strong Performance and Growth Potential Justifies Buy Rating Despite Cyber Cost Challenges
Barclays
$104
Buy
-8.01%
Downside
Assigned
11/13/24
Healthequity (HQY) Receives a Buy from Barclays
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Healthequity

1 Month
xxx
Success Rate
13/20 ratings generated profit
65%
Average Return
+0.80%
reiterated a xxx
rating yesterday
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 65.00% of your transactions generating a profit, with an average return of +0.80% per trade.
3 Months
xxx
Success Rate
13/20 ratings generated profit
65%
Average Return
+4.69%
reiterated a xxx
rating yesterday
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 65.00% of your transactions generating a profit, with an average return of +4.69% per trade.
1 Year
Stan BerenshteynWells Fargo
Success Rate
26/29 ratings generated profit
90%
Average Return
+18.58%
reiterated a buy rating 2 days ago
Copying Stan Berenshteyn's trades and holding each position for 1 Year would result in 89.66% of your transactions generating a profit, with an average return of +18.58% per trade.
2 Years
xxx
Success Rate
28/29 ratings generated profit
97%
Average Return
+32.32%
reiterated a xxx
rating 2 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 96.55% of your transactions generating a profit, with an average return of +32.32% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

HQY Analyst Recommendation Trends

Rating
Feb 25
Mar 25
Apr 25
May 25
Jun 25
Strong Buy
0
1
1
1
0
Buy
22
20
19
18
14
Hold
0
1
1
1
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
22
22
21
20
15
In the current month, HQY has received 14 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. HQY average Analyst price target in the past 3 months is 119.08.
Each month's total comprises the sum of three months' worth of ratings.

HQY Financial Forecast

HQY Earnings Forecast

Next quarter’s earnings estimate for HQY is $0.91 with a range of $0.85 to $1.00. The previous quarter’s EPS was $0.97. HQY beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.04% of the time in the same period. In the last calendar year HQY has Outperformed its overall industry.
Next quarter’s earnings estimate for HQY is $0.91 with a range of $0.85 to $1.00. The previous quarter’s EPS was $0.97. HQY beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.04% of the time in the same period. In the last calendar year HQY has Outperformed its overall industry.

HQY Sales Forecast

Next quarter’s sales forecast for HQY is $320.80M with a range of $313.56M to $327.24M. The previous quarter’s sales results were $330.84M. HQY beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 47.51% of the time in the same period. In the last calendar year HQY has Outperformed its overall industry.
Next quarter’s sales forecast for HQY is $320.80M with a range of $313.56M to $327.24M. The previous quarter’s sales results were $330.84M. HQY beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 47.51% of the time in the same period. In the last calendar year HQY has Outperformed its overall industry.

HQY Stock Forecast FAQ

What is HQY’s average 12-month price target, according to analysts?
Based on analyst ratings, Healthequity’s 12-month average price target is 119.08.
    What is HQY’s upside potential, based on the analysts’ average price target?
    Healthequity has 5.32% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is HQY a Buy, Sell or Hold?
          Healthequity has a consensus rating of Strong Buy which is based on 12 buy ratings, 1 hold ratings and 0 sell ratings.
            What is Healthequity’s price target?
            The average price target for Healthequity is 119.08. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $130.00 ,the lowest forecast is $104.00. The average price target represents 5.32% Increase from the current price of $113.06.
              What do analysts say about Healthequity?
              Healthequity’s analyst rating consensus is a Strong Buy. This is based on the ratings of 13 Wall Streets Analysts.
                How can I buy shares of HQY?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis